CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Cash Flows [Abstract]
Total cash, cash equivalents, and restricted cash	$ 25,340	$ 20,737	$ 25,935
Cash flows from operating activities
Net income/(loss)	(2,152)	17,910	(1,276)
Depreciation and tooling amortization	7,642	7,318	8,751
Other amortization	(1,149)	(1,358)	(1,294)
Held-for-sale impairment charges	32	0	23
Brazil manufacturing exit non-cash charges (excluding accelerated depreciation of $145, $322, and $17) (Note 21)	(82)	48	1,159
(Gains)/Losses on Extinguishment of Debt	121	1,702	1
Provision for/(Benefit from) credit and insurance losses	46	(298)	929
Pension and Other Postretirement Employee Benefits (OPEB) expense/(income)	(378)	(4,865)	1,027
Equity method investment dividends received in excess of (earnings)/losses and impairments	3,324	116	130
Foreign currency adjustments	(27)	532	(420)
Net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments	7,518	(9,159)	(315)
Net (gain)/loss on changes in investments in affiliates	147	(368)	(3,446)
Stock compensation (Note 6)	336	305	199
Provision for deferred income taxes	(1,910)	(563)	(269)
Increase (Decrease) in Finance Receivables	(10,560)	7,656	12,104
Decrease/(Increase) in accounts receivable and other assets	(1,183)	(1,141)	(63)
Decrease/(Increase) in inventory	(2,576)	(1,778)	148
Increase/(Decrease) in accounts payable and accrued and other liabilities	7,268	(36)	6,809
Other Operating Activities, Cash Flow Statement	436	(234)	72
Net cash provided by/(used in) operating activities	6,853	15,787	24,269
Cash flows from investing activities
Capital spending	(6,866)	(6,227)	(5,742)
Acquisitions of finance receivables and operating leases	(45,533)	(48,379)	(55,901)
Collections of finance receivables and operating leases	46,276	52,094	48,746
Proceeds from sale of business	449	145	1,340
Payments to Acquire Marketable Securities	(17,458)	(27,491)	(39,624)
Sales and maturities of marketable securities and other investments	19,117	33,229	32,395
Settlements of derivatives	94	(272)	(323)
Capital contributions to equity method investments	(738)	(57)	(4)
Other	312	(297)	498
Net Cash Provided by (Used in) Investing Activities	(4,347)	2,745	(18,615)
Cash flows from financing activities
Cash payments for dividends and dividend equivalents	(2,009)	(403)	(596)
Purchases of common stock	(484)	0	0
Net changes in short-term debt	5,460	3,273	(2,291)
Proceeds from issuance of long-term debt	45,470	27,901	65,900
Payments of long-term debt	(45,655)	(54,164)	(60,514)
Other	(271)	(105)	(184)
Net Cash Provided by (Used in) Financing Activities	2,511	(23,498)	2,315
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	(414)	(232)	225
Cash, cash equivalents, and restricted cash at beginning of period (Note 9)	20,737	25,935	17,741
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	4,603	(5,198)	8,194
Cash, cash equivalents, and restricted cash at end of period (Note 9)	$ 25,340	$ 20,737	$ 25,935